Oral versus intravenous vinorelbine: clinical safety profile

Author： Gebbia Vittorio Puozzo Christian

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.4, Iss.5, 2005-09, pp. : 915-928

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fluvastatin: Clinical and Safety Profile

By Corsini A.

Drugs, Vol. 64, Iss. 12, 2004-01 ,pp. : 1305-1323

Adis International

Access to resources Recommend Favorite

Pharmacological Management of PDA: Oral Versus Intravenous Medications

Current Clinical Pharmacology, Vol. 7, Iss. 4, 2012-11 ,pp. : 263-270

Bentham Science Publishers

Access to resources Recommend Favorite

Retrospective Analysis of the Safety Profile of Oral Moxifloxacin in Elderly Patients Enrolled in Clinical Trials

By Andriole Vincent T.

Drug Safety, Vol. 28, Iss. 5, 2005-01 ,pp. : 443-452

Adis International

Access to resources Recommend Favorite

Oral Versus Intramuscular Phytomenadione: Safety and Efficacy Compared

By von Kries R.

Drug Safety, Vol. 21, Iss. 1, 1999-07 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

Safety Profile of Lansoprazole: The US Clinical Trial Experience

By Freston J.W.

Drug Safety, Vol. 20, Iss. 2, 1999-02 ,pp. : 195-205

Adis International

Access to resources Recommend Favorite